SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-08-004041
Filing Date
2008-12-11
Accepted
2008-12-11 08:00:55
Documents
13
Period of Report
2008-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K w71909e8vk.htm 8-K 11532
2 EX-99.1 w71909exv99w1.htm EX-99.1 13440
3 EX-99.2 w71909exv99w2.htm EX-99.2 7335
4 GRAPHIC w71909w7190900.gif GRAPHIC 10460
5 GRAPHIC w71909w71909z0001.gif GRAPHIC 27780
6 GRAPHIC w71909w71909z0002.gif GRAPHIC 21994
7 GRAPHIC w71909w71909z0003.gif GRAPHIC 53235
8 GRAPHIC w71909w71909z0004.gif GRAPHIC 56580
9 GRAPHIC w71909w71909z0005.gif GRAPHIC 41463
10 GRAPHIC w71909w71909z0006.gif GRAPHIC 45252
11 GRAPHIC w71909w71909z0007.gif GRAPHIC 45483
12 GRAPHIC w71909w71909z0008.gif GRAPHIC 54780
13 GRAPHIC w71909w71909z0009.gif GRAPHIC 50905
  Complete submission text file 0000950133-08-004041.txt   597413
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 081242364
SIC: 2836 Biological Products, (No Diagnostic Substances)